Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery;Erholung von einer verlängerten, Rocurionium-induzierten, tiefen neuromuskulären Blockade: Ein randomisierter Vergleich der Reversion durch Sugammadex mit spontaner Erholung

Anaesthesist

Volumn 64, Issue 7, 2015, Pages 506-512

  Rahe Meyer, N ^a,b   Berger, C ^c   Wittmann, M ^d   Solomon, C ^b,e,f   Abels, E A M ^g,h   Rietbergen, H ^g   Reuter, D A ⁱ  

^a FRANZISKUS HOSPITAL   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f CSL BEHRING GMBH   (Germany)

^g Process Development and Commercialization   (Netherlands)

^h PHILIPS RESEARCH LABORATORIES   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Neuromuscular blockade; Placebo; Rocuronium; Sugammadex

Indexed keywords

DESFLURANE; PLACEBO; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUFENTANIL; SUGAMMADEX; THIOPENTAL; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ANESTHESIA; ARTICLE; BREATHING RATE; CONSTIPATION; CONTROLLED STUDY; CONVALESCENCE; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FLATULENCE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROMUSCULAR BLOCKING; OXYGEN SATURATION; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; VITAL SIGN; VOMITING; AGED; ANESTHETIC RECOVERY; BIOASSAY; CLINICAL TRIAL; DOSE RESPONSE; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; PROCEDURES; YOUNG ADULT;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; YOUNG ADULT;

EID: 84937971899     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-015-0048-0     Document Type: Article

References (17)

1. Baillard C, Gehan G, Reboul-Marty J et al (2000) Residual curarization in the recovery room after vecuronium. Br J Anaesth 84:394–395
2. Berg H, Roed J, Viby-Mogensen J et al (1997) Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 41:1095–1103
3. Murphy GS, Szokol JW, Marymont JH et al (2008) Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 107:130–137
4. Jones RK, Caldwell JE, Brull SJ, Soto RG (2008) Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 109:816–824
5. Plaud B, Debaene B, Donati F, Marty J (2010) Residual paralysis after emergence from anesthesia. Anesthesiology 112:1013–1022
6. Grayling M, Sweeney BP (2007) Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 62:806–809
7. Blobner M, Eriksson LI, Scholz J et al (2010) Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 27:874–881
8. Lemmens HJ, El-Orbany MI, Berry J et al (2010) Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine. BMC Anesthesiol 10:15
9. Khuenl-Brady KS, Wattwil M, Vanacker BF et al (2010) Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Anesth Analg 110:64–73
10. Fuchs-Buder T, Claudius C, Skovgaard LT et al (2007) Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 51:789–808
11. Aldrete JA (1995) The post-anesthesia recovery score revisited. J Clin Anesth 7:89–91
12. Bhananker SM, Posner KL, Cheney FW et al (2006) Injury and liability associated with monitored anesthesia care: a closed claims analysis. Anesthesiology 104:228–234
13. Geldner G, Niskanen M, Laurila P et al (2012) A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia 67:991–998
14. Duvaldestin P, Kuizenga K, Saldien V et al (2010) A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg 110:74–82
15. Maybauer DM, Geldner G, Blobner M et al (2007) Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia 62:12–17
16. Naguib M, Kopman AF, Lien CA et al (2010) A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 111:110–119
17. Ledowski T, Falke L, Johnston F et al (2014) Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol 31:423–429